Aurora Cannabis repays remainder of convertible senior debt
Aurora Cannabis says it has repaid the remaining balance of its convertible senior notes, a landmark in the Canadian producer’s efforts to cut its debt and save on interest payments.
Aurora Cannabis says it has repaid the remaining balance of its convertible senior notes, a landmark in the Canadian producer’s efforts to cut its debt and save on interest payments.
Aurora Cannabis appointed Simona King, a veteran executive of multinational pharmaceutical company Bristol Myers Squibb, as chief financial officer.
Aurora Cannabis has acquired the remaining 90% equity interest of MedReleaf Australia it didn’t already own, giving the Canadian marijuana producer a bigger foothold in one of the world’s biggest federally regulated medical markets.
Canadian producer Aurora Cannabis said it’s planning to consolidate its shares to restore compliance with the Nasdaq’s minimum bid-price requirement and ensure continued access to a range of institutional investors.
Some ingestible cannabis products that Health Canada considers noncompliant with federal rules still appear to be widely available in parts of the country, almost a year after the regulator asked companies to stop selling them to consumers because of concerns about overconsumption of THC.
Canadian licensed producer Aurora Cannabis has reached a settlement with Willow Biosciences over an ongoing patent litigation.
Canadian producer Aurora Cannabis received gross proceeds of 38.8 million Canadian dollars ($28.3 million) from a bought deal offering after the underwriters’ over-allotment option was fully exercised.
Much of the medical cannabis produced under Denmark’s regulatory regime has never made it to market and was intentionally destroyed for various reasons, according to government data.
Back in the regulated marijuana industry’s more heady days, a U.S. hemp-derived CBD subsidiary seemed like the must-have accessory for any Canadian cannabis company worth its bud.
A significant jump in plant-propagation sales and medical marijuana exports helped Canadian licensed producer Aurora Cannabis narrow its loss in the first quarter of fiscal year 2024 to 28.3 million Canadian dollars ($20 million).
In the face of slumping cannabis stock prices, publicly traded Canadian marijuana producers and U.S. ancillary companies are increasingly turning to share consolidations to maintain their listings on the Nasdaq exchange.
Canadian marijuana producer Aurora Cannabis closed on the sale of its enormous Sun greenhouse to Bevo Farms, although the exact value of the transaction was not disclosed.